1-5 of 5
Frank Firkin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naïve and Relapsed/Refractory Severe Aplastic Anaemia - the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials

Zoe McQuilten, Lucy C Fox, Vanessa Fox, Stephane Heritier, Tracey J Batt, Piers Blombery, Jennifer Curnow, Alisa Higgins, Devendra Hiwase, Robin J Filshie, Frank Firkin, Paul Lacaze, Kylie D Mason, Tony Mills, Sushrut S. Patil, Dominic Pepperell, William S Stevenson, Jeffrey Szer, Neil Waters, Kate Wilson, Stephen B Ting, Erica M. Wood
Journal: Blood
Blood (2022) 140 (Supplement 1): 2931–2932.
https://doi.org/10.1182/blood-2022-168963
Published: 2022
Journal Articles

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome

Clinical Trials & Observations
David C. Dale, Frank Firkin, Audrey Anna Bolyard, Merideth Kelley, Vahagn Makaryan, Kenneth J. Gorelick, Tarek Ebrahim, Varun Garg, Weihua Tang, Honghua Jiang, Renato Skerlj, Sarah Beaussant Cohen
Journal: Blood
Blood (2020) 136 (26): 2994–3003.
https://doi.org/10.1182/blood.2020007197
Published: 2020
Includes: Supplemental data
Journal Articles

Understanding Neutropenia: The 20 Year Experience of the Severe Chronic Neutropenia International Registry (SCNIR)

David C. Dale, MD, Audrey Anna Bolyard, RN, BS, Cornelia Zeidler, MDMPH, Tracy M. Marrero, Laurence A. Boxer, MD, Peter E. Newburger, MD, Blanche P. Alter, MD MPH, PK Morrow, MD, Mary Ann Bonilla, MD, Yigal Dror, MD FRCP(C), Frank Firkin, MBBS PhDFRACP FRCPA, Sally Kinsey, MD, John E. Levine, MD MS, Daniel C. Link, MD, Lee Reeves, Philip S. Rosenberg, PhD, Akiko Shimamura, MD PhD, Karl Welte, MD
Journal: Blood
Blood (2014) 124 (21): 2730.
https://doi.org/10.1182/blood.V124.21.2730.2730
Published: 2014
Journal Articles

Final Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 Trial: All- Trans Retinoic Acid (ATRA), Intravenous Arsenic Trioxide (ATO) and Idarubicin (IDA) As Initial Therapy for Acute Promyelocytic Leukemia (APL)

Harry J Iland, MBBS FRACP FRCPA, Marnie Collins, BCom BSc(Hons), Mark S Hertzberg, MBBS PhDFRACP FRCPA, Michael Seldon, MBBS FRACP FRCPA, Andrew P Grigg, MBBS FRACP FRCPA MD, Frank Firkin, MBBS PhDFRACP FRCPA, Shane G Supple, BSc(Hons) PhD, Lynda J Campbell, Kenneth F Bradstock, MBBS PhDFRACP FRCPA, John F Seymour, MBBS, FRACP, PhD
Journal: Blood
Blood (2014) 124 (21): 375.
https://doi.org/10.1182/blood.V124.21.375.375
Published: 2014
Journal Articles

All- trans -retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

CME
Harry J. Iland, Ken Bradstock, Shane G. Supple, Alberto Catalano, Marnie Collins, Mark Hertzberg, Peter Browett, Andrew Grigg, Frank Firkin, Amanda Hugman, John Reynolds, Juliana Di Iulio, Campbell Tiley, Kerry Taylor, Robin Filshie, Michael Seldon, John Taper, Jeff Szer, John Moore, John Bashford, John F. Seymour
Journal: Blood
Blood (2012) 120 (8): 1570–1580.
https://doi.org/10.1182/blood-2012-02-410746
Published: 2012